EQS-News: SÜSS MicroTec SE
/ Key word(s): Mergers & Acquisitions
Garching, November 8, 2023 – SÜSS MicroTec SE signed an agreement today for the sale of its Swiss subsidiary SUSS MicroOptics SA and the division by the same name to Focuslight (HK) Investment Management Co. Ltd., a subsidiary of the Shanghai (China) listed company Focuslight Technologies Inc. The transaction is expected to be completed in the first quarter of 2024 and is subject to pending approvals. The transaction volume amounts to € 75.5 million and includes the acquisition of all shares of SUSS MicroOptics and the redemption of financial debt. After successful closing of the sale, SUSS MicroTec group is expected to gain extraordinary income before taxes in a range of around € 40 to 45 million. “Following detailed analysis, the Management Board and Supervisory Board concluded in early 2023 that the MicroOptics division no longer fits in SUSS MicroTec’s core business due to the low synergies with our semiconductor equipment divisions. We are convinced that with Focuslight we have found an owner who can develop SUSS MicroOptics to its full potential,” says Burkhardt Frick, CEO of SÜSS MicroTec SE. Focuslight Technologies develops and manufactures with around 800 employees diode laser components as well as laser optics. Focuslight and SUSS MicroOptics have complementary product portfolios and serve customers in the automotive and medical technology sectors, among others. With the acquisition of photonics specialist LIMO from Dortmund (Germany), Focuslight already gained experience in the Western European markets 2017. Burkhardt Frick: “In return, SUSS MicroOptics has now the opportunity to gain further access to customers in new markets. Close cooperation in the areas of research and development, production and sales creates synergies in operating activities and forms the ideal foundation for further and accelerated growth. We like to thank the about 160 employees of SUSS MicroOptics for their great commitment to building up the company over the past few years and, together with Focuslight, wish them the greatest possible commercial success following the completion of the transaction.” In the 2022 fiscal year, the MicroOptics division contributed sales in the amount of EUR 39.2 million to the total sales of SUSS MicroTec. With effect from September 30, 2023, the MicroOptics division will appear in SUSS MicroTec’s financial reporting as a discontinued activity. For the full-year forecast for 2023, which was last adjusted on October 25, 2023, and in which MicroOptics was still included, this results in a recalculated sales forecast of € 280 million to € 320 million, an expected gross profit margin of 34% to 36%, and an EBIT margin of 7% to 11%.
Legal Disclaimer
08.11.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | SÜSS MicroTec SE |
Schleissheimer Strasse 90 | |
85748 Garching | |
Germany | |
Phone: | +49 (0)89 32007-161 |
Fax: | +49 (0)89 4444 33420 |
E-mail: | franka.schielke@suss.com |
Internet: | www.suss.com |
ISIN: | DE000A1K0235 |
WKN: | A1K023 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1768329 |
End of News | EQS News Service |
|
1768329 08.11.2023 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.